Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism (Q45281571)

11 December 2017

Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism (English)

1 reference

11 December 2017

M Artwohl

1

1 reference

11 December 2017

C Fürnsinn

2

1 reference

11 December 2017

W Waldhäusl

3

1 reference

11 December 2017

T Hölzenbein

4

1 reference

11 December 2017

G Rainer

5

1 reference

11 December 2017

A Freudenthaler

6

1 reference

11 December 2017

M Roden

7

1 reference

11 December 2017

S M Baumgartner-Parzer

8

1 reference

11 December 2017

24 February 2005

1 reference

11 December 2017

1 reference

11 December 2017

48

1 reference

11 December 2017

3

1 reference

11 December 2017

586-594

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-005-1672-z

11 December 2017

0 references

cites work

Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes

1 reference

12 December 2020

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

1 reference

12 December 2020

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

12 December 2020

Modulation by leptin of proliferation and apoptosis in vascular endothelial cells

1 reference

12 December 2020

Cyclin D3 is rate-limiting for the G1/S phase transition in fibroblasts

1 reference

12 December 2020

Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?

1 reference

12 December 2020

Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells

1 reference

12 December 2020

1 reference

12 December 2020

PPARgamma, the ultimate thrifty gene

1 reference

12 December 2020

Roles of PPARs in health and disease.

1 reference

12 December 2020

Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

1 reference

12 December 2020

Lack of effect of type II diabetes on the pharmacokinetics of troglitazone in a multiple-dose study.

1 reference

12 December 2020

Diabetic LDL triggers apoptosis in vascular endothelial cells

1 reference

12 December 2020

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

12 December 2020

The retinoblastoma protein and cell cycle control

1 reference

12 December 2020

1 reference

12 December 2020

E2F and cell proliferation: a world turned upside down

1 reference

12 December 2020

Response of experimental retinal neovascularization to thiazolidinediones

1 reference

12 December 2020

Oxidized low-density lipoprotein and 15-deoxy-delta 12,14-PGJ2 increase mitochondrial complex I activity in endothelial cells

1 reference

12 December 2020

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

1 reference

12 December 2020

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

1 reference

12 December 2020

Glucose and diabetic vascular disease.

1 reference

12 December 2020

Gemfibrozil considerably increases the plasma concentrations of rosiglitazone

1 reference

12 December 2020

Increased prevalence of microthromboses in retinal capillaries of diabetic individuals

1 reference

12 December 2020

Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes

1 reference

12 December 2020

p21(WAF1/Cip1): more than a break to the cell cycle?

1 reference

12 December 2020

Vascular targets of redox signalling in diabetes mellitus

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

12 December 2020

Glitazones regulate glutamine metabolism by inducing a cellular acidosis in MDCK cells

1 reference

12 December 2020

Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin

1 reference

12 December 2020

Causes and elimination of erratic blanks in enzymatic metabolite assays involving the use of NAD+ in alkaline hydrazine buffers: Improved conditions for the assay of l-glutamate, l-lactate, and other metabolites

1 reference

12 December 2020

Activation of PPAR gamma in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR gamma

1 reference

12 December 2020

Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes

1 reference

12 December 2020

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

1 reference

12 December 2020

PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

1 reference

12 December 2020

A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes

1 reference

12 December 2020

Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation

1 reference

12 December 2020

Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells

1 reference

12 December 2020

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

1 reference

12 December 2020

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

1 reference

12 December 2020

PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease

1 reference

12 December 2020

Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression

1 reference

12 December 2020

A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties

1 reference

12 December 2020

10.1007/S00125-005-1672-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference